Phathom Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-201.59	-197.72	-143.88	-129.07	-255.13	-1.29
Depreciation & Amortization	0.58	0.62	0.52	0.32	0.01	0
Share-Based Compensation	45.03	24.13	16.81	5.84	0.41	0
Other Operating Activities	18.41	26.44	-21.91	53.22	218.21	0.27
Operating Cash Flow	-137.58	-146.53	-148.46	-69.69	-36.51	-1.02
Capital Expenditures	-1.63	-1.04	-0.33	-1.04	-0.13	0
Other Investing Activities	-	-	-	-	-25.12	-
Investing Cash Flow	-1.63	-1.04	-0.33	-1.04	-25.25	0
Share Issuance / Repurchase	155.59	24.6	1.94	89.46	191.47	0
Debt Issued / Paid	211.99	95.45	42.76	25	113.17	1.9
Financing Cash Flow	367.58	120.04	44.71	114.46	304.65	1.9
Net Cash Flow	228.37	-27.53	-104.08	43.73	242.89	0.88
Free Cash Flow	-139.21	-147.57	-148.79	-70.73	-36.64	-1.02
Free Cash Flow Margin	-20412.61%	-	-	-	-	-
Free Cash Flow Per Share	-2.71	-3.77	-4.02	-2.13	-3.22	-0.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).